Systems and methods for determining nucleic acids

Patent metadata

Field	Value
Publication number	US-11098303-B2
Application number	US-201515329683-A
Country	US
Kind code	B2
Filing date	Jul 29, 2015
Priority date	Jul 30, 2014
Publication date	Aug 24, 2021
Grant date	Aug 24, 2021

Abstract

The present invention generally relates to systems and methods for imaging or determining nucleic acids, for instance, within cells. In some embodiments, the transcriptome of a cell may be determined. Certain embodiments are directed to determining nucleic acids, such as mRNA, within cells at relatively high resolutions. In some embodiments, a plurality of nucleic acid probes may be applied to a sample, and their binding within the sample determined, e.g., using fluorescence, to determine locations of the nucleic acid probes within the sample. In some embodiments, codewords may be based on the binding of the plurality of nucleic acid probes, and in some cases, the codewords may define an error-correcting code to reduce or prevent misidentification of the nucleic acids. In certain cases, a relatively large number of different targets may be identified using a relatively small number of labels, e.g., by using various combinatorial approaches.

First claim

The invention claimed is:

1. A method for detecting a plurality of different nucleic acid targets within a sample by in situ hybridization, comprising:
(a) producing a plurality of first hybridized complexes within a sample containing a plurality of different nucleic acid targets by exposing the sample to a plurality of different encoding nucleic acid probes,
wherein each of the plurality of encoding nucleic acid probes comprises (i) a target sequence that specifically hybridizes to a different nucleic acid target or a different location of an identical nucleic acid target of the plurality of different nucleic acid targets and (ii) one or more read sequences such that each of the plurality of first hybridized complexes comprises multiple encoding nucleic acid probes of the different encoding nucleic acid probes

(b) producing a plurality of readout probe-hybridized complexes by exposing each of the plurality of first hybridized complexes within the sample to a first readout nucleic acid probe, wherein the first readout nucleic acid probe comprises a first portion and a second portion, the first portion comprising a sequence that specifically hybridizes to one of the read sequences, and the second portion comprising a fluorescent signaling entity capable of producing a fluorescent signal;
(c) detecting a fluorescent signal from each of the plurality of readout probe-hybridized complexes;
(d) removing the fluorescent signal from each of the plurality of readout probe-hybridized complexes by inactivating the fluorescent signaling entity or removing the fluorescent signaling entity from each of the plurality of readout probe-hybridized complexes;
(e) after step (d), producing a different plurality of readout probe-hybridized complexes by exposing the sample to a different readout nucleic acid probe, wherein the different readout nucleic acid probe comprise a first portion and a second portion, the first portion comprising a sequence that specifically hybridizes to one of the read sequences, and the second portion comprising a fluorescent signaling entity capable of producing a fluorescent signal;
(f) detecting a fluorescent signal from each of the different plurality of readout probe hybridized complexes;
(g) removing the fluorescent signal from each of the different plurality of readout probe hybridized complexes by inactivating the fluorescent signaling entity or removing the fluorescent signaling entity from each of the different plurality of readout probe hybridized complexes;
(h) repeating steps (e) to (g) for one or more times using a different readout nucleic acid probe, wherein the different readout nucleic acid probe comprises a first portion and a second portion, the first portion comprising a sequence that specifically hybridizes to one of the read sequences, and the second portion comprising a fluorescent signaling entity capable of producing a fluorescent signal;
(i) producing codewords representing the plurality of different nucleic acid targets at locations within the sample, wherein each of the codeword represents one of the plurality of different nucleic acid targets and comprises multiple binary values 1 and 0, wherein a value of 1 is obtained when the fluorescent signal is detected from one of the plurality of readout probe hybridized complexes or one of the different plurality of readout probe-hybridized complexes at a respective location within the sample while a value of 0 is obtained when the fluorescent signal is not detected from one of the plurality of readout probe-hybridized complexes or one of the different plurality of readout probe-hybridized complexes at the respective location within the sample;
(j) matching the codewords with valid codewords in a codebook by comparing the codewords to the valid codewords in the codebook, and if one of the codewords is not matched with one of the valid codewords in the codebook, applying an error detection or correction system, matching the one of the codewords with another of the valid codewords in the codebook, or discarding the one of the codewords, wherein the codebook comprises the valid codewords of the plurality of nucleic acid targets; and
(k) determining the plurality of nucleic acid targets in the sample based on results from the matching step.

2. The method of claim 1 , wherein the fluorescent signal in step (c) and/or step (f) is detected at a resolution better than 300 nm.

3. The method of claim 1 , wherein the sample comprises a cell.

4. The method of claim 3 , wherein the cell is fixed on a coverslip.

5. The method of claim 1 , comprising determining the fluorescent signal entity by imaging at least a portion of the sample using a light microscope.

6. The method of claim 1 , further comprising determining an abundance and/or spatial distribution of the different nucleic acid targets at locations within the sample.

7. The method of claim 1 , further comprising removing the readout nucleic acid probes unhybridized to each of the plurality of first hybridized complex prior to step (c).

8. The method of claim 1 , wherein the valid codewords form an error-checking or an error-correcting code space.

9. The method of claim 1 , wherein in said comparing the codewords to the valid codewords in the codebook in step (j), one of the codewords is not matched with one of the valid codewords in the codebook when the one of the codewords has one or more errors.

10. The method of claim 1 , wherein in said comparing the codewords to the valid codewords in the codebook in step (j), one of the codewords is not matched with one of the valid codewords in the codebook when the one of the codewords has one error.

11. The method of claim 1 , wherein in said comparing the codewords to the valid codewords in the codebook in step (j), one of the codewords is not matched with one of the valid codewords in the codebook when the one of the codewords has two errors.

12. The method of claim 1 , wherein said comparing the codewords to the valid codewords in the codebook in step (j) comprises comparing the values at each of the positions of the codewords.

Assignees

• Harvard College

Inventors

• Zhuang Xiaowei
• Chen Kok-Hao
• Boettiger Alistair
• Moffitt Jeffrey R
• Wang Siyuan

Classifications

• G06N7/01

  Probabilistic graphical models, e.g. probabilistic networks · CPC title

• G16C20/10

  Analysis or design of chemical reactions, syntheses or processes · CPC title

• G16B25/20

  Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation · CPC title

• C07H21/04

  with deoxyribosyl as saccharide radical · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title